It was found that miR-155 regulates two newly identified targets, Foxp1 and GRB2-associated bind protein 1, and both of which regulate the BCR signaling, therefore, affect CLL growth and survival. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.